Novel risk model based on angiogenesis-related lncRNAs for prognosis prediction of hepatocellular carcinoma
暂无分享,去创建一个
H. Xia | Jinwei Zhong | Zhongjing Zhang | Jinglin Xia | Haizhen Ni | Zhijie Yu | Shicheng Xie | Xiuyan Kong | Yating Pan | Weiguo Huang | Xiaoben Lin
[1] I. Ng,et al. Hypoxia-induced macropinocytosis represents a metabolic route for liver cancer , 2022, Nature communications.
[2] Zhenqiang Sun,et al. Machine learning-based integration develops an immune-derived lncRNA signature for improving outcomes in colorectal cancer , 2022, Nature Communications.
[3] V. Mazzaferro,et al. Immunotherapies for hepatocellular carcinoma , 2021, Nature Reviews Clinical Oncology.
[4] Hongqiang Cheng,et al. Endothelial deletion of SHP2 suppresses tumor angiogenesis and promotes vascular normalization , 2021, Nature Communications.
[5] Xiaobin Wu,et al. c-Myc-activated intronic miR-210 and lncRNA MIR210HG synergistically promote the metastasis of gastric cancer. , 2021, Cancer letters.
[6] Rui Wang,et al. Linc-ROR facilitates progression and angiogenesis of hepatocellular carcinoma by modulating DEPDC1 expression , 2021, Cell Death & Disease.
[7] Y. Abe,et al. Immunovascular classification of HCC reflects reciprocal interaction between immune and angiogenic tumor microenvironments , 2021, Hepatology.
[8] Liqun He,et al. Role of Venous Endothelial Cells in Developmental and Pathologic Angiogenesis , 2021, Circulation.
[9] Zhiyan Zhu,et al. Single cell DNA sequencing reveals punctuated and gradual clonal evolution in hepatocellular carcinoma. , 2021, Gastroenterology.
[10] S. El-Nabi,et al. Genetic variants of APEX1 p.Asp148Glu and XRCC1 p.Gln399Arg with the susceptibility of hepatocellular carcinoma , 2021, Journal of medical virology.
[11] Qianlan Yao,et al. A Combined Long Noncoding RNA Signature as a Candidate Prognostic Biomarker for Ovarian Cancer , 2021, Frontiers in Oncology.
[12] Jun-Long Zhao,et al. Epigenetic silencing of miR-144/451a cluster contributes to HCC progression via paracrine HGF/MIF-mediated TAM remodeling , 2021, Molecular cancer.
[13] A. Jemal,et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries , 2021, CA: a cancer journal for clinicians.
[14] Courtney T. Griffin,et al. RIPK3 modulates growth factor receptor expression in endothelial cells to support angiogenesis , 2021, Angiogenesis.
[15] Maite Huarte,et al. Gene regulation by long non-coding RNAs and its biological functions , 2020, Nature reviews. Molecular cell biology.
[16] Weiguo Tang,et al. LncRNA MYLK-AS1 facilitates tumor progression and angiogenesis by targeting miR-424-5p/E2F7 axis and activating VEGFR-2 signaling pathway in hepatocellular carcinoma , 2020, Journal of Experimental & Clinical Cancer Research.
[17] R. Xu,et al. LncRNA‐mediated posttranslational modifications and reprogramming of energy metabolism in cancer , 2020, Cancer communications.
[18] E. D. De Toni,et al. The mechanisms of sorafenib resistance in hepatocellular carcinoma: theoretical basis and therapeutic aspects , 2020, Signal Transduction and Targeted Therapy.
[19] O. Chinot,et al. Bevacizumab (Avastin®) in cancer treatment: A review of 15 years of clinical experience and future outlook. , 2020, Cancer treatment reviews.
[20] Zhenfeng Zhang,et al. Dual Vascular Endothelial Growth Factor Receptor and Fibroblast Growth Factor Receptor Inhibition Elicits Antitumor Immunity and Enhances Programmed Cell Death-1 Checkpoint Blockade in Hepatocellular Carcinoma , 2020, Liver Cancer.
[21] Xia Li,et al. Pan-cancer characterization of immune-related lncRNAs identifies potential oncogenic biomarkers , 2020, Nature Communications.
[22] Baofeng Lian,et al. miR-17-5p and miR-20a-5p suppress postoperative metastasis of hepatocellular carcinoma via blocking HGF/ERBB3-NF-κB positive feedback loop , 2020, Theranostics.
[23] T. Pawlik,et al. Long-term Effects of Repeat Hepatectomy vs Percutaneous Radiofrequency Ablation Among Patients With Recurrent Hepatocellular Carcinoma: A Randomized Clinical Trial. , 2019, JAMA oncology.
[24] Shuang Liu,et al. Long non-coding RNA LUCAT1 promotes proliferation and invasion in gastric cancer by regulating miR-134-5p/YWHAZ axis. , 2019, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.
[25] S. Germain,et al. Extracellular matrix scaffolding in angiogenesis and capillary homeostasis. , 2019, Seminars in cell & developmental biology.
[26] Ling-Ling Chen,et al. Cellular functions of long noncoding RNAs , 2019, Nature Cell Biology.
[27] C. Vanhove,et al. Angiopoietin‐2 Promotes Pathological Angiogenesis and Is a Therapeutic Target in Murine Nonalcoholic Fatty Liver Disease , 2019, Hepatology.
[28] Weijia Li,et al. MIR210HG predicts poor prognosis and functions as an oncogenic lncRNA in hepatocellular carcinoma. , 2019, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.
[29] Xiaoliang Xu,et al. Long non‐coding RNA LUCAT1 promotes tumourigenesis by inhibiting ANXA2 phosphorylation in hepatocellular carcinoma , 2018, Journal of cellular and molecular medicine.
[30] M. Helmy,et al. Chemopreventive and antitumor effects of benzyl isothiocynate on HCC models: A possible role of HGF /pAkt/ STAT3 axis and VEGF. , 2018, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.
[31] R. Finn,et al. The Role of Angiogenesis in Hepatocellular Carcinoma , 2018, Clinical Cancer Research.
[32] J. Mendell,et al. Functional Classification and Experimental Dissection of Long Noncoding RNAs , 2018, Cell.
[33] Kshitij Srivastava,et al. Pericyte-expressed Tie2 controls angiogenesis and vessel maturation , 2017, Nature Communications.
[34] Yibo Gao,et al. LncRNA profile study reveals a three-lncRNA signature associated with the survival of patients with oesophageal squamous cell carcinoma , 2014, Gut.
[35] A. Villanueva,et al. Emerging Signaling Pathways in Hepatocellular Carcinoma , 2012, Liver Cancer.
[36] Ash A. Alizadeh,et al. SUPPLEMENTARY NOTE , 1879, Botanical Gazette.
[37] Hui Liu,et al. The effect of TACE in combination with thalidomide-mediated adjuvant therapy on the levels of VEGF and bFGF in patients with hepatocellular carcinoma. , 2021, American journal of translational research.
[38] Pui Yan Yeung,et al. Revealing lncRNA Structures and Interactions by Sequencing-Based Approaches. , 2019, TIBS -Trends in Biochemical Sciences. Regular ed.
[39] Hilde van der Togt,et al. Publisher's Note , 2003, J. Netw. Comput. Appl..